Pre-Open Stock Movers:
Veru, Inc. (NASDAQ:VERU) 38% HIGHER; COVID-19 drug candidate reduced deaths by 55% in hospitalized COVID patients in Phase 3 trial. Due to "overwhelming" efficacy of the study, the Independent Data Safety Monitoring Committee unanimously recommended that the Phase 3 study be halted, and they further remarked that no safety concerns were identified.
SailPoint Technologies Holdings, Inc. (NYSE:SAIL) 30% HIGHER; agreed to acquired by Thoma Bravo in an all-cash transaction that values SailPoint at approximately $6.9 billion.
Affimed N.V. (Nasdaq: NASDAQ:AFMD) 15% HIGHER; presented "highly encouraging" data for lead innate cell engager AFM13 precomplexed with cord blood-derived natural killer (cbNK) cells.
Nio Inc (NYSE:NIO) 9% LOWER; will increase the prices for three of its models and battery rental service BaaS (Battery as a Service). Also announced that it had suspended production at its Hefei, Anhui province factory due to Covid-related restrictions.
Eton Pharmaceuticals, Inc. (Nasdaq: NASDAQ:ETON) 8% HIGHER; received final approval from the U.S. Food and Drug Administration (FDA) for its cysteine hydrochloride abbreviated new drug application (ANDA), a bioequivalent generic of Exela Pharma Sciences Elcys.
Li Auto Inc. (LI) 6% LOWER; COVID lock-downs in China hurting production.
Tesla, Inc. (NASDAQ:TSLA) 4% LOWER; COVID lock-downs in China hurting production.
NVIDIA (NASDAQ:NVDA) 4% LOWER; Baird downgraded from Outperform to Neutral with a price target of $225.00 (from $360.00).
Twitter (NYSE:TWTR) 1% LOWER; Elon Musk, the company's largest shareholder, informed the management he won't be joining the board.